Matrix rigidity regulates the transition of tumor cells to a bone-destructive phenotype through integrin beta 3 and TGF- beta receptor type II
Cancer patients frequently develop skeletal metastases that significantly impact quality of life. Since bone metastases remain incurable, a clearer understanding of molecular mechanisms regulating skeletal metastases is required to develop new therapeutics that block establishment of tumors in bone....
Gespeichert in:
Veröffentlicht in: | Biomaterials 2015-09, Vol.64, p.33-44 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!